MODIFIED CLOSED CIRCULAR DNA (CCDNA) CONTAINING SYMMETRIC MODIFIED INVERTED END REPEATED SEQUENCES Russian patent published in 2024 - IPC C12N15/63 C12N15/85 C12N15/86 A61P7/00 A61P35/00 A61P25/00 

Abstract RU 2816963 C2

FIELD: biotechnology.

SUBSTANCE: described is a group of inventions comprising a non-viral capsid-free DNA vector with covalently closed ends (ccDNA vector) for delivering nucleic acid, a ccDNA expression construct which codes ccDNA, a host cell for producing the ccDNA expression construct, method of producing a ccDNA vector, using a composition comprising a ccDNA vector for treating, preventing, relieving, monitoring or diagnosing a disease or disorder in a subject, a method of delivering a therapeutic protein to a subject, a kit for delivering a nucleic acid and a kit for producing a ccDNA vector. In one embodiment, the ccDNA vector comprises a nucleic acid sequence flanked by two symmetric ITRs which are not wild-type ITRs.

EFFECT: invention extends the range of means for delivering nucleic acid.

56 cl, 29 dwg, 7 tbl, 9 ex

Similar patents RU2816963C2

Title Year Author Number
MODIFIED CLOSED-ENDED DNA (scDNA) 2018
  • Kotin, Robert Majkl
  • Alkan, Ozan
  • Dzhons, Annalize
  • Kerr, Duglas Entoni
  • Malakian, Ara Karl
  • Simmons, Metyu Dzhon
  • Rajt, Tereza L.
RU2800026C2
MODULATION OF REP PROTEIN ACTIVITY WHEN PRODUCING CLOSED-END DNA (ceDNA) 2020
  • Kotin, Robert, Majkl
  • Ucher, Anna
  • Malakyan, Ara, Karl
RU2812850C2
GENE EDITING USING MODIFIED CLOSED-END DNA (ceDNA) 2018
  • Kotin, Robert Majkl
  • Kerr, Duglas
  • Samajoa, Fillip
  • Alkan, Ozan
  • Simmons, Mettyu Dzh.
RU2811724C2
CLOSED-ENDED DNA VECTORS OBTAINED BY CELL-FREE SYNTHESIS, AND METHOD OF PRODUCING CEDNA VECTORS 2019
  • Alkan, Ozan
  • Kotin, Robert Majkl
  • Stanton, Metyu
  • Kerr, Duglas Entoni
  • Pelleter, Karolin
RU2820586C2
NON-VIRAL DNA VECTORS AND OPTIONS FOR THEIR USE FOR EXPRESSION OF THERAPEUTIC AGENT BASED ON PHENYLALANINE HYDROXYLASE (PAH) 2020
  • Kerr, Duglas Antoni
  • Samajoa, Fillip
  • Silver, Nataniel
  • Chiokko, Mettyu
RU2814137C2
NON-VIRAL DNA VECTORS AND THEIR USE FOR THE PRODUCTION OF ANTIBODIES AND FUSION PROTEINS 2019
  • Alkan, Ozan
  • Kerr, Duglas Entoni
  • Kotin, Robert Majkl
  • Klatte, Debra
  • Liu, Lea
  • Silver, Nataniel
RU2800914C2
NON-VIRAL DNA VECTORS AND OPTIONS FOR THEIR USE FOR EXPRESSION OF THERAPEUTIC AGENT BASED ON FACTOR VIII (FVIII) 2020
  • Kerr, Duglas, Antoni
  • Klatte, Debra
  • Samajoa, Fillip
  • Silver, Nataniel
RU2812852C2
CONTROLLED EXPRESSION OF TRANSGENES USING CLOSED-END DNA VECTORS (ceDNA) 2019
  • Kerr, Duglas A.
  • Stanton, Metyu Dzh.
  • Chiokko, Mett
  • Angelino, Mark D.
  • Kotin, Robert M.
  • Samajoa, Fillip
RU2816871C2
MODULATING POLYNUCLEOTIDES 2015
  • Hou, Jinzhao
  • Nonnenmacher, Mathieu E.
  • Zhou, Pengcheng
RU2749882C2
MODULATING POLYNUCLEOTIDES 2015
  • Hou Jinzhao
  • Nonnenmacher Mathieu E.
  • Zhou Pengcheng
RU2719192C2

RU 2 816 963 C2

Authors

Kotin, Robert Majkl

Alkan, Ozan

Dzhons, Annalize

Dates

2024-04-08Published

2019-11-08Filed